美容整形手術及び処置のヨーロッパ市場2020-2132

◆英語タイトル:EUROPE COSMETIC SURGERY AND PROCEDURE MARKET FORECAST 2020-2028
◆商品コード:INK20MY183
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2020年5月
◆ページ数:134
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:ヨーロッパ
◆販売価格オプション(消費税別)
Single UserUSD1,250 ⇒換算¥131,250見積依頼/購入/質問フォーム
Multi LicenseUSD1,500 ⇒換算¥157,500見積依頼/購入/質問フォーム
Enterprisewide PriceUSD2,000 ⇒換算¥210,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Inkwood Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

KEY FINDINGSThe cosmetic surgery and procedure market in Europe is anticipated to register a CAGR of 5.65% during the projected period of 2020-2028. One of the important factors boosting the market growth in the region is increasing interest in cosmetic procedures from Eastern Europe.

MARKET INSIGHTS
In order to study the European market of cosmetic surgery and procedure further, the region is segregated into countries such as Belgium, France, Russia, Italy, the UK, Germany, Poland, and the rest of Europe that includes Switzerland, Greece, Spain, NORDIC, and others. In Russia, the market for plastic surgery has grown considerably over the last decade, with around 100 million-dollar business. It is not only very common among Russian women to opt for surgery to look younger and attractive but also among Russian men, which is boosting the market growth. Belgium is a popular destination for British people seeking surgery abroad, including cosmetic and plastic surgery, owing to low prices and easy travel by Eurostar. Clinic BeauCare is one of the leading providers of breast enlargement surgery in the country.
In Poland, the highest level of skilled surgical, nursing, and medical care across a range of high-quality cosmetic surgery procedures is available. Moreover, there is a rise in medical tourism due to increased awareness of Poland as a tourist destination, the increasing number of budget airlines flying from Britain to Polish cities in particular, and the difference in cost between cosmetic and dental surgery in Poland and more economically-developed countries. In the rest of Europe, there is substantial demand for cosmetic procedures collectively from the constituting countries. In Spain, private clinics employ the largest number of plastic surgeons in Europe.

COMPETITIVE INSIGHTS
Galderma, Merz Pharma, Ipsen S.A, Sinclair Pharma PLC, Johnson & Johnson, etc. are some of the well-known companies functioning in the market.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

【レポートの目次】

1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. MARKET DEFINITION
3.2. KEY DRIVERS
3.2.1. RISE IN AGING POPULATION
3.2.2. RAPID GROWTH OF THE AESTHETIC INDUSTRY
3.2.3. MEDICAL TOURISM IN DEVELOPING MARKETS
3.2.4. PREFERENCE FOR MINIMALLY INVASIVE AND NON-INVASIVE PROCEDURES OVER INVASIVE PROCEDURES
3.2.5. SURGE IN DISPOSABLE INCOME
3.3. KEY RESTRAINTS
3.3.1. HIGH RATE OF AESTHETIC USAGES
3.3.2. DIFFICULTIES RELATED TO COSMETIC TREATMENT
3.3.3. HIGH COST OF IMPLANTABLE MEDICAL DEVICES
3.3.4. SAFETY CONCERNS RELATED TO BREAST IMPLANT
3.3.5. AVAILABILITY OF ALTERNATIVE TREATMENTS
3.3.6. LACK OF REIMBURSEMENT
4. KEY ANALYTICS
4.1. PORTER’S FIVE FORCE ANALYSIS
4.1.1. THREAT OF NEW ENTRY
4.1.2. THREAT OF SUBSTITUTION
4.1.3. BUYER’S POWER
4.1.4. SUPPLIER’S POWER
4.1.5. COMPETITIVE RIVALRY
4.2. MARKET TRENDS
4.3. VALUE CHAIN ANALYSIS
4.4. REGULATORY FRAMEWORK
4.5. OPPORTUNITY MATRIX
4.6. VENDOR LANDSCAPE
4.7. KEY INVESTMENT INSIGHTS
5. MARKET BY TYPE
5.1. SURGICAL
5.1.1. BREAST AUGMENTATION
5.1.2. LIPOSUCTION
5.1.3. EYELID SURGERY
5.1.4. TUMMY TUCK
5.1.5. BREAST LIFT
5.1.6. OTHER SURGICAL TYPES
5.2. NON-SURGICAL
5.2.1. BOTULINUM TOXIN
5.2.2. DERMAL FILLERS
5.2.3. LASER HAIR REMOVAL
5.2.4. CHEMICAL PEEL
5.2.5. MICRODERMABRASION
5.2.6. PHOTO-REJUVENATION
5.2.7. OTHER NON-SURGICAL TYPES
6. GEOGRAPHICAL ANALYSIS
6.1. EUROPE
6.1.1. GERMANY
6.1.2. THE UNITED KINGDOM
6.1.3. FRANCE
6.1.4. ITALY
6.1.5. RUSSIA
6.1.6. BELGIUM
6.1.7. POLAND
6.1.8. REST OF EUROPE
7. COMPANY PROFILES
7.1. ALLERGAN PLC
7.2. ALMA LASERS LTD (ACQUIRED BY FOSUN PHARMA)
7.3. BAUSCH HEALTH COMPANIES INC (FORMERLY VALEANT PHARMACEUTICALS)
7.4. CANDELA CORP (FORMERLY SYNERON MEDICAL LTD)
7.5. CUTERA INC
7.6. CYNOSURE (ACQUIRED BY CLAYTON, DUBILIER & RICE)
7.7. DEPUY SYNTHES COMPANIES (ACQUIRED BY JOHNSON & JOHNSON)
7.8. GALDERMA (ACQUIRED BY EQT)
7.9. IPSEN S.A.
7.10. JOHNSON & JOHNSON
7.11. LUMENIS LTD
7.12. MERZ PHARMA
7.13. SIENTRA INC
7.14. SINCLAIR PHARMA PLC



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[美容整形手術及び処置のヨーロッパ市場2020-2132]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆